{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:15:17Z","timestamp":1790950517046,"version":"4.1.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/bor.0b013e3283474d62","type":"journal-article","created":{"date-parts":[[2011,4,26]],"date-time":"2011-04-26T03:52:41Z","timestamp":1303789961000},"page":"377-384","source":"Crossref","is-referenced-by-count":56,"title":["Interferon-gamma release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders"],"prefix":"10.1097","volume":"23","author":[{"given":"Rachel","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adithya","family":"Cattamanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen R","family":"Steingart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Denkinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keertan","family":"Dheda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin L","family":"Winthrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhukar","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210128","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-11-20210128","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ncprheum0336","article-title":"Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor","volume":"2","author":"Winthrop","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"R3-11-20210128","first-page":"43","article-title":"The risk and prevention of tuberculosis: screening strategies to detect latent tuberculosis among rheumatoid arthritis patients who use biologic therapy","volume":"8","author":"Winthrop","year":"2010","journal-title":"Int J Adv Rheumatol"},{"key":"R4-11-20210128","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement.","volume":"36","author":"Solovic","year":"2010","journal-title":"Eur Respir J"},{"key":"R5-11-20210128","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMcp021045","article-title":"Clinical practice. Latent tuberculosis infection","volume":"347","author":"Jasmer","year":"2002","journal-title":"N Engl J Med"},{"key":"R6-11-20210128","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/0003-4819-126-3-199702010-00005","article-title":"Reliability of tuberculin skin test measurement","volume":"126","author":"Pouchot","year":"1997","journal-title":"Ann Intern Med"},{"key":"R9-11-20210128","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1586\/14737159.6.3.413","article-title":"New tools and emerging technologies for the diagnosis of tuberculosis. Part I. Latent tuberculosis","volume":"6","author":"Pai","year":"2006","journal-title":"Expert Rev Mol Diagn"},{"key":"R10-11-20210128","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"key":"R11-11-20210128","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/509927","article-title":"Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis?","volume":"44","author":"Pai","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R12-11-20210128","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1183\/09031936.00114810","article-title":"Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis","volume":"37","author":"Sester","year":"2011","journal-title":"Eur Respir J"},{"key":"R13-11-20210128","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"R14-11-20210128","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and nontuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"R15-11-20210128","doi-asserted-by":"crossref","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG World Atlas: a database of global BCG vaccination policies and practices.","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med"},{"key":"R16-11-20210128","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis","volume":"56","author":"Cattamanchi","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R17-11-20210128","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MCP.0b013e32832a0adc","article-title":"T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings","volume":"15","author":"Dheda","year":"2009","journal-title":"Curr Opin Pulm Med"},{"key":"R19-11-20210128","doi-asserted-by":"crossref","first-page":"e10508","DOI":"10.1371\/journal.pone.0010508","article-title":"Evaluation of the prognostic value of IFN-gamma release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal","volume":"5","author":"Lienhardt","year":"2010","journal-title":"PLoS One"},{"key":"R20-11-20210128","doi-asserted-by":"crossref","first-page":"e1379","DOI":"10.1371\/journal.pone.0001379","article-title":"Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts","volume":"3","author":"Hill","year":"2008","journal-title":"PLoS One"},{"key":"R21-11-20210128","doi-asserted-by":"crossref","first-page":"e8257","DOI":"10.1371\/journal.pone.0008257","article-title":"IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia","volume":"4","author":"Del Corral","year":"2009","journal-title":"PLoS One"},{"key":"R22-11-20210128","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-149-11-200812020-00248","article-title":"Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact","volume":"149","author":"Bakir","year":"2008","journal-title":"Ann Intern Med"},{"key":"R23-11-20210128","doi-asserted-by":"crossref","first-page":"e17984","DOI":"10.1371\/journal.pone.0017984","article-title":"The Tuberculin Skin Test Versus QuantiFERON TB Gold in predicting tuberculosis disease in an Adolescent Cohort Study in South Africa.","volume":"6","author":"Mahomed","year":"2011","journal-title":"PLoS One"},{"key":"R24-11-20210128","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nrmicro2236-c1","article-title":"Spectrum of latent tuberculosis - existing tests cannot resolve the underlying phenotypes","volume":"8","author":"Pai","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"R25-11-20210128","doi-asserted-by":"crossref","first-page":"e8517","DOI":"10.1371\/journal.pone.0008517","article-title":"Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review","volume":"4","author":"Van Zyl-Smit","year":"2009","journal-title":"PLoS One"},{"key":"R26-11-20210128","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.00107608","article-title":"QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases","volume":"33","author":"Bartalesi","year":"2009","journal-title":"Eur Respir J"},{"key":"R27-11-20210128","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3899\/jrheum.080854","article-title":"Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy","volume":"36","author":"Behar","year":"2009","journal-title":"J Rheumatol"},{"key":"R28-11-20210128","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10096-008-0519-1","article-title":"Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment","volume":"27","author":"Bocchino","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R29-11-20210128","first-page":"1177","article-title":"Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers","volume":"11","author":"Cobanoglu","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"R30-11-20210128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10238-009-0082-9","article-title":"Comparison of tuberculin skin test and QuantiFERON-TB gold in tube test in patients with chronic inflammatory diseases living in a tuberculosis endemic population","volume":"10","author":"Gogus","year":"2009","journal-title":"Clin Exp Med"},{"key":"R31-11-20210128","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/ard.2009.113829","article-title":"Comparison of two interferon-gamma release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases","volume":"69","author":"Kleinert","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R32-11-20210128","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10067-010-1550-z","article-title":"A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor alpha inhibitor.","volume":"30","author":"Kwakernaak","year":"2011","journal-title":"Clin Rheumatol"},{"key":"R33-11-20210128","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2133.2009.09331.x","article-title":"Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test","volume":"161","author":"Laffitte","year":"2009","journal-title":"Br J Dermatol"},{"key":"R35-11-20210128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/ard.2008.101857","article-title":"Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis","volume":"69","author":"Martin","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R36-11-20210128","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","article-title":"Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay","volume":"67","author":"Matulis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R37-11-20210128","first-page":"776","article-title":"Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population","volume":"35","author":"Ponce de Leon","year":"2008","journal-title":"J Rheumatol"},{"key":"R38-11-20210128","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.1572-0241.2008.02050.x","article-title":"Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease","volume":"103","author":"Schoepfer","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R39-11-20210128","first-page":"1271","article-title":"Usefulness of enzyme-linked immunosorbent assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for antitumor necrosis factor treatment","volume":"35","author":"Vassilopoulos","year":"2008","journal-title":"J Rheumatol"},{"key":"R40-11-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0029-1214673","article-title":"Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases","volume":"63","author":"Diel","year":"2009","journal-title":"Pneumologie"},{"key":"R41-11-20210128","first-page":"620","article-title":"Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy","volume":"137","author":"Beglinger","year":"2007","journal-title":"Swiss Med Wkly"},{"key":"R43-11-20210128","first-page":"51","article-title":"Recommendations for prophylaxis and management of tuberculosis in patients treated with TNF-\u03b1 antagonists","volume":"46","author":"Kucharz","year":"2008","journal-title":"Reumatologia"},{"key":"R44-11-20210128","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis Infection - United States, 2010.","volume":"59","year":"2010","journal-title":"MMWR"},{"key":"R45-11-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14745\/ccdr.v36i00a05","article-title":"Updated Recommendations on interferon gamma release assays for latent tuberculosis infection.","volume":"36","year":"2010","journal-title":"CCDR"},{"key":"R48-11-20210128","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.arbres.2010.02.010","article-title":"Consensus document on the diagnosis, treatment and prevention of tuberculosis","volume":"46","author":"Gonzalez-Martin","year":"2010","journal-title":"Arch Bronconeumol"},{"key":"R49-11-20210128","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement","volume":"36","author":"Solovic","year":"2010","journal-title":"Eur Respir J"},{"key":"R50-11-20210128","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4103\/0256-4947.59373","article-title":"Saudi guidelines for testing and treatment of latent tuberculosis infection","volume":"30","author":"Al Jahdali","year":"2010","journal-title":"Ann Saudi Med"},{"key":"R52-11-20210128","first-page":"498","article-title":"Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results","volume":"12","author":"Menzies","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"R53-11-20210128","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrrheum.2009.105","article-title":"Preventing and treating biologic-associated opportunistic infections","volume":"5","author":"Winthrop","year":"2009","journal-title":"Nat Rev Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e3283474d62","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:29:19Z","timestamp":1786044559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-201107000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3283474d62","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}